CDSCO Medical Device Registration: Foreign Manufacturer Import License

India's Medical Device Market: Why Foreign Manufacturers Are Entering

India's medical device market is valued at approximately USD 14 billion as of 2025 and projected to reach USD 50 billion by 2030, driven by rising healthcare expenditure, hospital infrastructure expansion, and government programmes like Ayushman Bharat that extend insurance coverage to 500 million citizens. India currently imports approximately 80% of its medical devices — creating a massive opportunity for foreign manufacturers. Foreign direct investment in medical devices is permitted at 100% under the automatic route.

But market access requires regulatory clearance from the Central Drugs Standard Control Organisation (CDSCO), India's equivalent of the US FDA or the EU's notified bodies. The Medical Devices Rules (MDR) 2017, which brought medical devices under the Drugs and Cosmetics Act, 1940, established a risk-based classification system and mandatory licensing regime that all foreign manufacturers must comply with before importing devices into India.

This guide covers the end-to-end CDSCO registration process for foreign manufacturers, including device classification, the Indian Authorized Agent requirement, Form MD-14 application, Form MD-15 import license, and practical timelines and costs current as of March 2026.

Regulatory Framework: Medical Devices Rules 2017

The MDR 2017 replaced the earlier notification-based system with a comprehensive regulatory framework. Key features include:

• Risk-based classification: Medical devices are classified into four categories (Class A, B, C, D) based on their risk profile, mirroring the Global Harmonisation Task Force (GHTF) classification system
• Mandatory licensing: All medical devices (except non-sterile, non-measuring Class A devices) require either a manufacturing license or an import license before they can be sold in India
• Central and state regulation: Class C and D devices are regulated by CDSCO (Central Licensing Authority), while Class A and B devices fall under State Licensing Authorities (SLAs)
• Online submission: All applications are processed through the SUGAM online portal at sugam.cdsco.gov.in

CDSCO's Role

CDSCO operates under the Ministry of Health and Family Welfare and serves as India's national regulatory authority for medical devices, pharmaceuticals, and clinical trials. For medical device imports, CDSCO evaluates applications, conducts technical reviews through Subject Expert Committees (SECs), and issues import licenses in Form MD-15. CDSCO's headquarters is in New Delhi, with zonal offices in Mumbai, Kolkata, Chennai, Hyderabad, Ahmedabad, and Ghaziabad.

Medical Device Classification: Class A Through D

India's risk-based classification system determines the regulatory pathway, documentation requirements, and review timelines for each device.

Classification Implications for Foreign Manufacturers

Higher-risk classifications require more extensive documentation, longer review timelines, and higher fees. Class C and D devices typically require clinical investigation data or substantial equivalence evidence, while Class A (sterile) and B devices may proceed with product testing and quality system documentation alone. Foreign manufacturers should confirm their device classification before beginning the registration process — an incorrect classification can result in rejected applications and months of delay.

The Indian Authorized Agent (IAA) Requirement

Foreign manufacturers cannot apply directly to CDSCO for an import license. Under Rule 18 of the MDR 2017, all import license applications must be submitted by an Indian entity authorised to act on the foreign manufacturer's behalf.

Who Can Be an IAA?

The Indian Authorized Agent must hold one of the following valid licenses:

• A wholesale license for sale or distribution of medical devices (Form MD-42)
• A manufacturing license for medical devices
• A registration certificate for the sale of notified medical devices

The IAA assumes full legal responsibility for regulatory compliance in India. This includes filing the import license application, coordinating with CDSCO during the review process, handling post-market surveillance obligations, managing adverse event reporting, and facilitating product recalls if required.

Appointing the IAA: Documentation

The foreign manufacturer must execute a Power of Attorney (PoA) in favour of the IAA, notarised and apostilled (or legalised) in the manufacturer's home country. The PoA must specifically authorise the IAA to apply for and manage the import license on behalf of the manufacturer. The apostille process follows the Hague Convention framework — countries that are not Hague Convention members must legalise documents through embassy attestation.

Choosing the Right IAA

The IAA selection is a critical strategic decision. Key considerations include:

• Regulatory experience: Does the IAA have a track record of successful CDSCO submissions? How many MD-15 licenses has it secured?
• License validity: Verify that the IAA's wholesale or manufacturing license is current and covers medical devices (not just pharmaceuticals)
• Conflict of interest: Is the IAA also representing a competitor's device in the same category?
• Post-market capability: Can the IAA handle adverse event reporting, recalls, and annual license retention fee payments?

Step-by-Step Import License Process

The import license process involves four stages, from pre-submission preparation through CDSCO approval.

Stage 1: Pre-Submission Preparation (1-2 Months)

1. Device classification confirmation: Verify the device classification under India's MDR 2017 Schedule I, comparing with the GHTF classification and any CDSCO-specific notifications
2. IAA appointment: Execute and apostille the Power of Attorney. Ensure the IAA has a valid MD-42 wholesale license
3. Document compilation: Gather all technical documentation (see checklist below)
4. SUGAM portal registration: The IAA registers on CDSCO's SUGAM online portal (sugam.cdsco.gov.in) and creates the application profile

Stage 2: Form MD-14 Application Submission

The IAA submits the import license application in Form MD-14 through the SUGAM portal. The application must include:

• Manufacturer details: Name, address, factory premises, legal constitution, country of origin
• Product details: Device name, intended use, classification, model numbers, technical specifications
• Quality certifications: Valid ISO 13485 certificate (Quality Management System for Medical Devices) and CE marking certificate (if applicable)
• Free Sale Certificate (FSC): Issued by the national regulatory authority of the country of origin, confirming the device is legally marketed in that country
• Certificate of Analysis: Test reports for the device from an accredited laboratory
• Manufacturing process details: Including sterilisation methods, raw material specifications, and quality control procedures
• Clinical data: Clinical investigation reports, substantial equivalence documentation, or clinical evaluation reports depending on device classification
• Labelling and instructions for use: Must comply with Indian labelling requirements under MDR 2017
• Power of Attorney: Apostilled PoA authorising the IAA
• IAA wholesale license: Copy of valid Form MD-42

Stage 3: CDSCO Review and Technical Evaluation

After submission, CDSCO reviews the application through the following process:

1. Administrative screening: CDSCO checks completeness of the application. Deficient applications are returned with a deficiency letter within 30-45 days
2. Technical evaluation: For Class C and D devices, the application is referred to a Subject Expert Committee (SEC) comprising medical professionals, engineers, and regulatory scientists. The SEC may request additional data, invite the IAA for a technical presentation, or recommend approval
3. Site inspection (if required): CDSCO may conduct a remote or in-person audit of the foreign manufacturer's facility. This is more common for Class D devices and novel technology platforms
4. Approval recommendation: The SEC recommends approval, rejection, or additional data requirements to the CDSCO licensing authority

Stage 4: Form MD-15 Import License Issuance

Upon approval, CDSCO issues the import license in Form MD-15. The license specifies the device name, classification, manufacturer details, IAA details, and any conditions of approval.

License Validity and Renewal

The Form MD-15 import license is valid in perpetuity — it does not have a fixed expiry date. However, a license retention fee must be paid every five years from the date of issue to maintain the license's active status. Failure to pay the retention fee results in the license being deemed cancelled.

Timelines by Device Classification

CDSCO's official target for processing import license applications is 270 days (approximately 9 months) from complete submission. In practice, timelines vary based on the SEC meeting schedule (typically monthly), the quality of the initial submission, and whether additional data or facility audits are required.

Fees and Cost Structure

CDSCO fees are modest by global regulatory standards, but the total cost of registration includes consultant fees, IAA fees, and documentation costs that significantly exceed government charges.

Government Fees

Total Registration Cost Estimate

Including regulatory consultant fees (INR 3-8 lakh per device), IAA retainer fees (INR 1-3 lakh per year), document preparation and apostille costs (INR 50,000-1,50,000), and testing and certification fees (varies widely), the total cost for a single Class C or D device registration typically ranges from INR 5-15 lakh (approximately USD 6,000-18,000). Multi-device portfolios benefit from economies of scale as many documents are shared across registrations.

Common Pitfalls for Foreign Manufacturers

1. Incorrect Device Classification

India's classification may differ from the EU MDR or US FDA classification for the same device. A device classified as Class II in the US may be Class C or D in India. Always cross-reference with the CDSCO notified device list and Schedule I of the MDR 2017.

2. Expired or Invalid FSC

The Free Sale Certificate must be current and issued by the regulatory authority (not a trade association or chamber of commerce). Some manufacturers submit FSCs from non-regulatory bodies, which CDSCO rejects.

3. Missing ISO 13485 Certification

ISO 13485 certification is mandatory for all import license applications. The certificate must cover the specific manufacturing facility producing the device for export to India. Multi-site certificates are acceptable only if they explicitly list the relevant facility.

4. Inadequate Clinical Data for Class C/D Devices

CDSCO increasingly requires clinical data demonstrating device performance in the Indian patient population or a substantially equivalent clinical context. Relying solely on CE marking or FDA clearance without supporting clinical data can delay approval by 3-6 months while additional evidence is gathered.

5. IAA License Gaps

If the IAA's wholesale license (Form MD-42) expires during the registration process, the application is rendered invalid. Verify the IAA's license validity and renewal timeline before commencing the registration.

Post-Market Requirements

Obtaining the Form MD-15 import license is not the end of regulatory obligations. Foreign manufacturers must comply with ongoing post-market requirements.

• Adverse event reporting: The IAA must report serious adverse events to CDSCO within defined timelines — typically 10 days for deaths and 15 days for serious injuries
• Product recalls: If a safety issue is identified, the IAA must coordinate with CDSCO on recall procedures and customer notifications
• Quality system maintenance: ISO 13485 certification must be maintained continuously. CDSCO may audit compliance
• Labelling compliance: All devices imported into India must carry labelling in English, with specific information mandated by the MDR 2017 (device name, UDI, manufacturer details, batch number, date of manufacture/expiry)
• Annual returns: The IAA must file annual returns with CDSCO reporting the quantity and value of devices imported

Recent Regulatory Developments (2025-2026)

Loan License Clarification

In 2025, CDSCO clarified that manufacturers using an already-licensed sterilisation facility do not need a separate loan license for sterilisation. This reduces documentation requirements and speeds up approvals for devices requiring third-party sterilisation.

Unique Device Identification (UDI)

CDSCO is implementing a phased UDI requirement. Class C and D devices must carry UDI barcodes, with Class A and B devices expected to follow. Foreign manufacturers should integrate UDI labelling into their production processes for India-bound shipments.

BIS Certification Requirements

For certain medical devices that also fall under Bureau of Indian Standards (BIS) certification requirements — particularly electronics-based devices — a separate BIS certification may be required in addition to the CDSCO import license. This is a parallel process, not a prerequisite for CDSCO registration, but must be completed before commercial import.

For foreign medical device manufacturers evaluating India market entry, our FDI advisory service covers entity structuring, regulatory pathway analysis, and IAA selection. See our glossary entry on Import Export Code for customs clearance requirements, our guide on foreign company registration in India for those considering a local subsidiary alongside their import license strategy, and our overview of customs duty implications for medical device imports.

Key Takeaways

• Foreign manufacturers must appoint an Indian Authorized Agent (IAA) with a valid wholesale license (Form MD-42) to apply for a CDSCO import license — direct applications are not accepted
• Medical devices are classified into four risk categories (Class A-D), with higher classifications requiring more extensive clinical data, SEC review, and longer processing timelines of up to 12 months
• The import license (Form MD-15) is valid in perpetuity, subject to payment of a license retention fee every five years — making India a relatively stable regulatory environment once initial approval is obtained
• ISO 13485 certification and a valid Free Sale Certificate from the country of origin are mandatory prerequisites for all import license applications
• Total registration cost ranges from INR 5-15 lakh per device (USD 6,000-18,000) including government fees, consultant fees, and documentation costs, with multi-device portfolios benefiting from economies of scale